Conducting Psychedelic Trials: Five Legal Considerations to Ensure Compliance and Success
- June 16, 2023
- Kimberly Chew , Husch Blackwell LLP
Psychedelic drugs are currently the subject of multiple clinical trials and are making scientific news as potential life-changing therapies for disorders such as posttraumatic stress disorder (PTSD), major depressive disorder, obsessive compulsive disorder, short-lasting unilateral neuralgiform headache attacks (SUNHA), fibromyalgia, anxiety disorders, and behavioral conditions such as cocaine use, smoking cessation, and binge eating disorder.
ARTICLE TAGS
You must be logged in to access this content.